Log In
Print
BCIQ
Print
Print this Print this
 

Rx-04

  Manage Alerts
Collapse Summary General Information
Company Melinta Therapeutics Inc.
DescriptionBroad spectrum multi-drug resistant Gram-negative and Gram-positive antibiotic
Molecular Target Ribosomal 50S subunit
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today